Suppr超能文献

Using a chemiresistor-based alkane sensor to distinguish exhaled breaths of lung cancer patients from subjects with no lung cancer.

作者信息

Tan Jiunn-Liang, Yong Zheng-Xin, Liam Chong-Kin

机构信息

Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Methodist College Kuala Lumpur, Kuala Lumpur, Malaysia.

出版信息

J Thorac Dis. 2016 Oct;8(10):2772-2783. doi: 10.21037/jtd.2016.10.30.

Abstract

BACKGROUND

Breath alkanes are reported to be able to discriminate lung cancer patients from healthy people. A simple chemiresistor-based sensor was designed to respond to alkanes by a change in resistance measured by a digital multimeter connected to the sensor. In preclinical experiments, the sensor response was found to have a strong positive linear relationship with alkane compounds and not responsive to water. This study aimed to determine the ability of the alkane sensor to distinguish the exhaled breaths of lung cancer patients from that of chronic obstructive pulmonary disease (COPD) patients and control subjects without lung cancer.

METHODS

In this cross-sectional study, 12 treatment-naive patients with lung cancer, 12 ex- or current smokers with COPD and 13 never-smokers without lung disease were asked to exhale through a drinking straw into a prototype breath-in apparatus made from an empty 125 mL Vitagen bottle with the chemiresistor sensor attached at its inside bottom to measure the sensor peak output (percentage change of baseline resistance measured before exhalation to peak resistance) and the time taken for the baseline resistance to reach peak resistance.

RESULTS

Analysis of multivariate variance and post-hoc Tukey test revealed that the peak output and the time to peak values for the lung cancer patients were statistically different from that for both the COPD patients and the controls without lung disease, Pillai's Trace =0.393, F=3.909, df = (4, 64), P=0.007. A 2.20% sensor peak output and a 90-s time to peak gave 83.3% sensitivity and 88% specificity in diagnosing lung cancer. Tobacco smoking did not affect the diagnostic accuracy of the sensor.

CONCLUSIONS

The alkane sensor could discriminate patients with lung cancer from COPD patients and people without lung disease. Its potential utility as a simple, cheap and non-invasive test for early lung cancer detection needs further studies.

摘要

相似文献

3
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
Lung Cancer. 2009 May;64(2):166-70. doi: 10.1016/j.lungcan.2008.08.008. Epub 2008 Oct 1.
4
Detection of lung cancer in exhaled breath with an electronic nose using support vector machine analysis.
J Breath Res. 2017 Aug 21;11(3):036009. doi: 10.1088/1752-7163/aa7799.
5
Exhaled breath temperature in patients with stable and exacerbated COPD.
J Breath Res. 2014 Sep 18;8(4):046002. doi: 10.1088/1752-7155/8/4/046002.
6
Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose.
IEEE Trans Biomed Eng. 2015 Aug;62(8):2044-54. doi: 10.1109/TBME.2015.2409092. Epub 2015 Mar 11.
7
Volatile signature for the early diagnosis of lung cancer.
J Breath Res. 2016 Feb 9;10(1):016007. doi: 10.1088/1752-7155/10/1/016007.
8
Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
Am J Respir Crit Care Med. 2009 Dec 1;180(11):1076-82. doi: 10.1164/rccm.200906-0939OC. Epub 2009 Aug 27.

引用本文的文献

1
The electronic nose in lung cancer diagnostics: a systematic review and meta-analysis.
ERJ Open Res. 2025 May 19;11(3). doi: 10.1183/23120541.00723-2024. eCollection 2025 May.
2
Collection methods of exhaled volatile organic compounds for lung cancer screening and diagnosis: a systematic review.
J Thorac Dis. 2024 Nov 30;16(11):7978-7998. doi: 10.21037/jtd-24-1001. Epub 2024 Nov 29.
3
MOF-Based Platform for Kidney Diseases: Advances, Challenges, and Prospects.
Pharmaceutics. 2024 Jun 11;16(6):793. doi: 10.3390/pharmaceutics16060793.
4
Diagnostic Performance of Electronic Noses in Cancer Diagnoses Using Exhaled Breath: A Systematic Review and Meta-analysis.
JAMA Netw Open. 2022 Jun 1;5(6):e2219372. doi: 10.1001/jamanetworkopen.2022.19372.
5
Breath Analysis: A Promising Tool for Disease Diagnosis-The Role of Sensors.
Sensors (Basel). 2022 Feb 6;22(3):1238. doi: 10.3390/s22031238.
6
Synthetic Biology Approaches to Hydrocarbon Biosensors: A Review.
Front Bioeng Biotechnol. 2022 Jan 10;9:804234. doi: 10.3389/fbioe.2021.804234. eCollection 2021.
8
Electronic Nose as a Novel Method for Diagnosing Cancer: A Systematic Review.
Biosensors (Basel). 2020 Jul 25;10(8):84. doi: 10.3390/bios10080084.

本文引用的文献

1
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease.
Curr Top Med Chem. 2016;16(14):1610-30. doi: 10.2174/1568026616666151223113540.
2
Comparison of classification methods in breath analysis by electronic nose.
J Breath Res. 2015 Dec 15;9(4):046002. doi: 10.1088/1752-7155/9/4/046002.
3
Volatile organic compounds in asthma diagnosis: a systematic review and meta-analysis.
Allergy. 2016 Feb;71(2):175-88. doi: 10.1111/all.12793. Epub 2015 Nov 13.
5
Cancer statistics, 2015.
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
8
Is previous respiratory disease a risk factor for lung cancer?
Am J Respir Crit Care Med. 2014 Sep 1;190(5):549-59. doi: 10.1164/rccm.201402-0338OC.
9
Breath analysis in disease diagnosis: methodological considerations and applications.
Metabolites. 2014 Jun 20;4(2):465-98. doi: 10.3390/metabo4020465.
10
Exhaled breath analysis for lung cancer.
J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S540-50. doi: 10.3978/j.issn.2072-1439.2013.08.44.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验